Mei Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mei Dong has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Guipeng An
State Key Laboratory for Innovation and Transformation of Luobing Theory
3 shared publicationsHuixia Lu
State Key Laboratory for Innovation and Transformation of Luobing Theory
3 shared publications- Huixia Lu
State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, China
3 shared publications Lei Wang
State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China; Department of Critical Care Medicine, Qilu Hospital, Shandong University; Innovation Research Center for Sepsis and Multiple Organ Injury, Shandong University, China
3 shared publicationsLianyue Ma
State Key Laboratory for Innovation and Transformation of Luobing Theory
3 shared publicationsXiangjuan Liu
State Key Laboratory for Innovation and Transformation of Luobing Theory
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1937732
Serum creatinine- and cystatin C-derived sarcopenia-related indices and the risk of all-cause mortality in patients undergoing transcatheter aortic valve implantation
Background: Sarcopenia is increasingly recognized as an important predictor of adverse outcomes after transcatheter aortic valve implantation (TAVI). However, the prognostic relevance of sarcopenia-related indices derived from serum creatinine and cystatin C in patients undergoing TAVI has not been fully established. Methods: This prospective study included 465 patients who underwent TAVI for symptomatic aortic stenosis. Associations between sarcopenia-related indices and all-cause mortality were assessed using Kaplan–Meier survival analysis, Cox proportional hazards models, and restricted cubic spline analysis (RCS). Predictive performance and incremental prognostic value were compared across indices using time-dependent receiver operating characteristic curves (ROC), the Harrell’s C-index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Subgroup and sensitivity analyses were performed to examine the robustness of the findings. Results: During a median follow-up of 2.8 years, 59 (12.7%) deaths occurred. In the fully adjusted Cox model, each 1-standard deviation increase in eGFRcys/eGFRcr (HR 0.29, 95% CI 0.11–0.75; p = 0.011) and Cr * eGFRcys (HR 0.30, 95% CI 0.14–0.64; p = 0.002) was associated with a lower risk of all-cause mortality. Time-dependent ROC indicated that Cr * eGFRcys had the most favorable predictive performance among the evaluated indices. Adding Cr * eGFRcys to the fully adjusted model increased the concordance index from 0.696 to 0.736 and significantly improved risk reclassification and discrimination (NRI: 0.437, 95% CI 0.171–0.704, p = 0.001; IDI: 0.026, 95% CI 0.004–0.048, p = 0.022). Findings from subgroup and sensitivity analyses were broadly consistent. Conclusion: Among patients with symptomatic aortic stenosis undergoing TAVI, lower eGFRcys/eGFRcr and Cr * eGFRcys were associated with a higher risk of all-cause mortality after the procedure. Notably, Cr * eGFRcys showed stronger prognostic value and may provide additional prognostic information for risk stratification in patients undergoing TAVI.
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1937732
Open AccessSerum creatinine- and cystatin C-derived sarcopenia-related indices and the risk of all-cause mortality in patients undergoing transcatheter aortic valve implantation
Background: Sarcopenia is increasingly recognized as an important predictor of adverse outcomes after transcatheter aortic valve implantation (TAVI). However, the prognostic relevance of sarcopenia-related indices derived from serum creatinine and cystatin C in patients undergoing TAVI has not been fully established. Methods: This prospective study included 465 patients who underwent TAVI for symptomatic aortic stenosis. Associations between sarcopenia-related indices and all-cause mortality were assessed using Kaplan–Meier survival analysis, Cox proportional hazards models, and restricted cubic spline analysis (RCS). Predictive performance and incremental prognostic value were compared across indices using time-dependent receiver operating characteristic curves (ROC), the Harrell’s C-index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Subgroup and sensitivity analyses were performed to examine the robustness of the findings. Results: During a median follow-up of 2.8 years, 59 (12.7%) deaths occurred. In the fully adjusted Cox model, each 1-standard deviation increase in eGFRcys/eGFRcr (HR 0.29, 95% CI 0.11–0.75; p = 0.011) and Cr * eGFRcys (HR 0.30, 95% CI 0.14–0.64; p = 0.002) was associated with a lower risk of all-cause mortality. Time-dependent ROC indicated that Cr * eGFRcys had the most favorable predictive performance among the evaluated indices. Adding Cr * eGFRcys to the fully adjusted model increased the concordance index from 0.696 to 0.736 and significantly improved risk reclassification and discrimination (NRI: 0.437, 95% CI 0.171–0.704, p = 0.001; IDI: 0.026, 95% CI 0.004–0.048, p = 0.022). Findings from subgroup and sensitivity analyses were broadly consistent. Conclusion: Among patients with symptomatic aortic stenosis undergoing TAVI, lower eGFRcys/eGFRcr and Cr * eGFRcys were associated with a higher risk of all-cause mortality after the procedure. Notably, Cr * eGFRcys showed stronger prognostic value and may provide additional prognostic information for risk stratification in patients undergoing TAVI.
- Open Access
- 18 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (15) , 107398
Obstructive Hypertrophic Cardiomyopathy With Degenerative Mitral Regurgitation
- 18 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (15) , 107398
Open AccessObstructive Hypertrophic Cardiomyopathy With Degenerative Mitral Regurgitation
- Open Access
- 2 January 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1732507
Balloon dilation in sheath technique in transcatheter aortic valve replacement via narrow femoral artery: first-in-human early feasibility study
Background: Severe aortic stenosis (AS) imposes sustained pressure overload on the left ventricle, leading to hypertrophy and myocardial fibrosis, which are key features of adverse cardiac remodeling. Timely transcatheter aortic valve replacement (TAVR) may reverse these processes. Transfemoral access remains the primary access method for TAVR, but the limited technique restricts early intervention in patients with narrow femoral arteries. This study aimed to evaluate the safety and feasibility of a novel balloon dilation in sheath (BinS) technique designed to facilitate transfemoral TAVR in such patients. Methods: This multicenter, prospective, and first-in-human early feasibility study included patients with severe AS and challenging femoral anatomy who underwent TAVR using the BinS technique between February 2023 and August 2024. The primary endpoint was the 30-day rate of major adverse events. The secondary endpoint was the rate of major adverse events at 6 months. The clinical endpoints included major post-procedural complications. Results: Fifteen patients (mean age 73.5 ± 7.3 years; 66.7% male) were treated successfully with the BinS technique via transfemoral access. There were no cases of all-cause mortality, stroke/transient ischemic attack, or severe major vascular access site complications defined by Valve Academic Research Consortium (VARC)-3 at both 30 days and 6 months. No myocardial infarction or paravalvular leakage was observed. 12 patients obtained VARC-3 technical success. Two patients experienced postprocedural arterial dissection, and two developed new-onset conduction abnormalities (left bundle branch block or permanent pacemaker implantation). At 30 days, left ventricular ejection fraction improved significantly from 50.8 ± 17.0% pre-procedure to 59.9 ± 14.6% post-procedure ( p < 0.001). Conclusion: The BinS technique appears to be a safe and effective method for enlarging the narrow femoral lumens during TAVR. By broadening transfemoral TAVR eligibility, this approach may permit earlier hemodynamic unloading, thereby mitigating adverse cardiac remodeling and potentially improving long-term outcomes. Larger, longer-term studies are warranted to confirm these findings.
- 2 January 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1732507
Open AccessBalloon dilation in sheath technique in transcatheter aortic valve replacement via narrow femoral artery: first-in-human early feasibility study
Background: Severe aortic stenosis (AS) imposes sustained pressure overload on the left ventricle, leading to hypertrophy and myocardial fibrosis, which are key features of adverse cardiac remodeling. Timely transcatheter aortic valve replacement (TAVR) may reverse these processes. Transfemoral access remains the primary access method for TAVR, but the limited technique restricts early intervention in patients with narrow femoral arteries. This study aimed to evaluate the safety and feasibility of a novel balloon dilation in sheath (BinS) technique designed to facilitate transfemoral TAVR in such patients. Methods: This multicenter, prospective, and first-in-human early feasibility study included patients with severe AS and challenging femoral anatomy who underwent TAVR using the BinS technique between February 2023 and August 2024. The primary endpoint was the 30-day rate of major adverse events. The secondary endpoint was the rate of major adverse events at 6 months. The clinical endpoints included major post-procedural complications. Results: Fifteen patients (mean age 73.5 ± 7.3 years; 66.7% male) were treated successfully with the BinS technique via transfemoral access. There were no cases of all-cause mortality, stroke/transient ischemic attack, or severe major vascular access site complications defined by Valve Academic Research Consortium (VARC)-3 at both 30 days and 6 months. No myocardial infarction or paravalvular leakage was observed. 12 patients obtained VARC-3 technical success. Two patients experienced postprocedural arterial dissection, and two developed new-onset conduction abnormalities (left bundle branch block or permanent pacemaker implantation). At 30 days, left ventricular ejection fraction improved significantly from 50.8 ± 17.0% pre-procedure to 59.9 ± 14.6% post-procedure ( p < 0.001). Conclusion: The BinS technique appears to be a safe and effective method for enlarging the narrow femoral lumens during TAVR. By broadening transfemoral TAVR eligibility, this approach may permit earlier hemodynamic unloading, thereby mitigating adverse cardiac remodeling and potentially improving long-term outcomes. Larger, longer-term studies are warranted to confirm these findings.
- Open Access
- 29 January 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-17
Exploring the role of oxidative stress in carotid atherosclerosis: insights from transcriptomic data and single-cell sequencing combined with machine learning
Carotid atherosclerotic plaque is the primary cause of cardiovascular and cerebrovascular diseases. It is closely related to oxidative stress and immune inflammation. This bioinformatic study was conducted to identify key oxidative stress-related genes and key immune cell infiltration involved in the formation, progression, and stabilization of plaques and investigate the relationship between them. We show that the up-regulation of oxidative stress-related genes such as IDH1 and CD36 in resident-like macrophages and foam macrophages play a key role in the formation and progression of carotid atherosclerotic plaques. We discuss the role of oxidative stress and immune inflammation in the formation, progression, and stabilization of plaques by combining predictive models with analysis of single-cell data. It introduced novel insights into the mechanisms underlying carotid atherosclerosis formation and plaque progression and may assist in identifying potential therapeutic targets for their treatment.
- 29 January 2025
- Published by Springer Nature in Biology Direct
- Vol. 20 (1) , 1-17
Open AccessExploring the role of oxidative stress in carotid atherosclerosis: insights from transcriptomic data and single-cell sequencing combined with machine learning
Carotid atherosclerotic plaque is the primary cause of cardiovascular and cerebrovascular diseases. It is closely related to oxidative stress and immune inflammation. This bioinformatic study was conducted to identify key oxidative stress-related genes and key immune cell infiltration involved in the formation, progression, and stabilization of plaques and investigate the relationship between them. We show that the up-regulation of oxidative stress-related genes such as IDH1 and CD36 in resident-like macrophages and foam macrophages play a key role in the formation and progression of carotid atherosclerotic plaques. We discuss the role of oxidative stress and immune inflammation in the formation, progression, and stabilization of plaques by combining predictive models with analysis of single-cell data. It introduced novel insights into the mechanisms underlying carotid atherosclerosis formation and plaque progression and may assist in identifying potential therapeutic targets for their treatment.
- Open Access
- 7 November 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 1034860
Case report: Heart failure secondary to myocardial infarction in a fertile woman with woven coronary artery
A 42-year-old female was hospitalized with 2-day history of fever, dyspnea, and chest tightness. Four years ago, she had similar symptoms at the eighth week of gestation. Computed tomography coronary angiography only suggested moderate stenosis, but cardiac MRI indicated myocardial infarction. The coronary angiography demonstrated a woven coronary artery. She underwent successful coronary artery bypass grafting surgery and took medication regularly. Finally, the prognosis was favorable. Cardiovascular events seldom happen in fertile women because of the protection of estrogen, but once it occurs, the potential cause, such as coronary anomaly and other risk factors, should not be overlooked.
- 7 November 2022
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 1034860
Open AccessCase report: Heart failure secondary to myocardial infarction in a fertile woman with woven coronary artery
A 42-year-old female was hospitalized with 2-day history of fever, dyspnea, and chest tightness. Four years ago, she had similar symptoms at the eighth week of gestation. Computed tomography coronary angiography only suggested moderate stenosis, but cardiac MRI indicated myocardial infarction. The coronary angiography demonstrated a woven coronary artery. She underwent successful coronary artery bypass grafting surgery and took medication regularly. Finally, the prognosis was favorable. Cardiovascular events seldom happen in fertile women because of the protection of estrogen, but once it occurs, the potential cause, such as coronary anomaly and other risk factors, should not be overlooked.
- 23 September 2021
- Published by SAGE Publications in Human Gene Therapy
- Vol. 32 (17-18) , 875-881
Regulatory T Cells and Diabetes Mellitus
Immune system dysfunction causes dysregulation of immune homeostasis, which in turn leads to autoimmune diseases. Regulatory T cells (Tregs) are a specialized T cell subpopulation that maintain peripheral tolerance and immune homeostasis. Diabetic patients are at an increased risk of developing cardiovascular diseases; thus, in terms of coronary risk, diabetes mellitus (DM) is considered coronary heart disease equivalent. Accumulating evidence indicates that Tregs play an important role in protecting against the development of various cardiovascular diseases. In this review, we provide an overview of the role of Tregs in the pathogenesis of DM, including type 1 DM, type 2 DM, latent autoimmune diabetes of adults, and gestational DM. In addition, we discuss the role of Tregs in diabetic complications, including cardiovascular diseases, nephropathy, neuropathy, and retinopathy. Tregs play a beneficial role in the pathogenesis of DM and diabetic complications, although the precise molecular mechanisms underlying the protective effect of Tregs against DM are still obscure. Collectively, modification of Tregs may provide a promising and novel future strategy for the prevention and therapy of DM and diabetic complications.
- 23 September 2021
- Published by SAGE Publications in Human Gene Therapy
- Vol. 32 (17-18) , 875-881
Regulatory T Cells and Diabetes Mellitus
Immune system dysfunction causes dysregulation of immune homeostasis, which in turn leads to autoimmune diseases. Regulatory T cells (Tregs) are a specialized T cell subpopulation that maintain peripheral tolerance and immune homeostasis. Diabetic patients are at an increased risk of developing cardiovascular diseases; thus, in terms of coronary risk, diabetes mellitus (DM) is considered coronary heart disease equivalent. Accumulating evidence indicates that Tregs play an important role in protecting against the development of various cardiovascular diseases. In this review, we provide an overview of the role of Tregs in the pathogenesis of DM, including type 1 DM, type 2 DM, latent autoimmune diabetes of adults, and gestational DM. In addition, we discuss the role of Tregs in diabetic complications, including cardiovascular diseases, nephropathy, neuropathy, and retinopathy. Tregs play a beneficial role in the pathogenesis of DM and diabetic complications, although the precise molecular mechanisms underlying the protective effect of Tregs against DM are still obscure. Collectively, modification of Tregs may provide a promising and novel future strategy for the prevention and therapy of DM and diabetic complications.
- Open Access
- 28 May 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF
Background: Atherosclerosis is closely associated with proliferation of the adventitial vasa vasorum, leading to the atherosclerotic plaque progression and vulnerability. In this report, we investigated the role of Ginsenoside Rb1 (Rb1) on atherosclerotic plaque stabilization and adventitial vasa vasorum (VV) along with the mechanisms involved.Methods and Results: Apolipoprotein E-deficient (ApoE−/−) mice were fed with a high-fat diet for 20 weeks, and then Ginsenoside Rb1 (50 mg/kg/d, intraperitoneal) was given for 4 weeks. Rb1 treatment significantly inhibited adventitial VV proliferation, alleviated inflammation, decreased plaque burden, and stabilized atherosclerotic plaques in apoE−/− mice. However, the beneficial effects of Rb1 on atherosclerotic lesion was attenuated by overexpression of miR-33. The analysis from atherosclerotic plaque revealed that Rb1 treatment could result in an induction of Pigment epithelium-derived factor (PEDF) expression and reduction of the miR-33 generation. Overexpression of miR-33 significantly reverted the Rb1-mediated elevation of PEDF and anti-angiogenic effect.Conclusions: Ginsenoside Rb1 attenuates plaque growth and enhances plaque stability partially through inhibiting adventitial vasa vasorum proliferation and inflammation in apoE−/− mice. The anti-angiogenic and anti-inflammation effects of Rb1 are exerted via the modulation of miR-33 and its target gene PEDF.
- 28 May 2021
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Open AccessGinsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF
Background: Atherosclerosis is closely associated with proliferation of the adventitial vasa vasorum, leading to the atherosclerotic plaque progression and vulnerability. In this report, we investigated the role of Ginsenoside Rb1 (Rb1) on atherosclerotic plaque stabilization and adventitial vasa vasorum (VV) along with the mechanisms involved.Methods and Results: Apolipoprotein E-deficient (ApoE−/−) mice were fed with a high-fat diet for 20 weeks, and then Ginsenoside Rb1 (50 mg/kg/d, intraperitoneal) was given for 4 weeks. Rb1 treatment significantly inhibited adventitial VV proliferation, alleviated inflammation, decreased plaque burden, and stabilized atherosclerotic plaques in apoE−/− mice. However, the beneficial effects of Rb1 on atherosclerotic lesion was attenuated by overexpression of miR-33. The analysis from atherosclerotic plaque revealed that Rb1 treatment could result in an induction of Pigment epithelium-derived factor (PEDF) expression and reduction of the miR-33 generation. Overexpression of miR-33 significantly reverted the Rb1-mediated elevation of PEDF and anti-angiogenic effect.Conclusions: Ginsenoside Rb1 attenuates plaque growth and enhances plaque stability partially through inhibiting adventitial vasa vasorum proliferation and inflammation in apoE−/− mice. The anti-angiogenic and anti-inflammation effects of Rb1 are exerted via the modulation of miR-33 and its target gene PEDF.
- Open Access
- 17 August 2020
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 17 (1) , 1-11
Aquaporin 7 involved in GINSENOSIDE-RB1-mediated anti-obesity via peroxisome proliferator-activated receptor gamma pathway
Background: Obesity, characterized by the excessive accumulation of triglycerides in adipocytes and their decreased excretion from adipocytes, is closely related to various health problems. Ginsenoside Rb1 (Rb1), the most active component of the traditional Chinese medicine ginseng, has been reported to have positive effects on lipid metabolism. The aim of the present study was to determine the protective effects of Rb1 on glycolipid metabolism under obesity conditions and its mechanisms and to reveal the signaling pathways involved. Methods: In our study, male C57BL/6 mice with obesity induced by a high-fat diet (HFD) and mature 3 T3-L1 adipocytes were used to investigate the role of Rb1 in lipid accumulation and explore its possible molecular mechanism in vivo and in vitro, respectively. Results: Rb1 reduced the body weight, fat mass, adipocytes size and serum free fatty acid (FFA) concentration of obese mice. In differentiated 3 T3-L1 adipocytes, Rb1 reduced the accumulation of lipid droplets and stimulated output of triglycerides. Additionally, the expression of peroxisome proliferator-activated receptor gamma (PPARγ), phosphorylated PPARγ (Ser112) and aquaporin 7 (AQP7) was upregulated in adipocytes and adipose tissues upon Rb1 treatment. However, intervention of GW9662, PPARγ antagonist, attenuated Rb1-mediated effects on glycolipid metabolism and AQP7 levels. Conclusions: These data indicated that Rb1 reduced body weight and improved glycolipid metabolism by upregulating PPARγ and AQP7 protein levels. Our study indicated a potential role for Rb1 in the prevention and treatment of obesity.
- 17 August 2020
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 17 (1) , 1-11
Open AccessAquaporin 7 involved in GINSENOSIDE-RB1-mediated anti-obesity via peroxisome proliferator-activated receptor gamma pathway
Background: Obesity, characterized by the excessive accumulation of triglycerides in adipocytes and their decreased excretion from adipocytes, is closely related to various health problems. Ginsenoside Rb1 (Rb1), the most active component of the traditional Chinese medicine ginseng, has been reported to have positive effects on lipid metabolism. The aim of the present study was to determine the protective effects of Rb1 on glycolipid metabolism under obesity conditions and its mechanisms and to reveal the signaling pathways involved. Methods: In our study, male C57BL/6 mice with obesity induced by a high-fat diet (HFD) and mature 3 T3-L1 adipocytes were used to investigate the role of Rb1 in lipid accumulation and explore its possible molecular mechanism in vivo and in vitro, respectively. Results: Rb1 reduced the body weight, fat mass, adipocytes size and serum free fatty acid (FFA) concentration of obese mice. In differentiated 3 T3-L1 adipocytes, Rb1 reduced the accumulation of lipid droplets and stimulated output of triglycerides. Additionally, the expression of peroxisome proliferator-activated receptor gamma (PPARγ), phosphorylated PPARγ (Ser112) and aquaporin 7 (AQP7) was upregulated in adipocytes and adipose tissues upon Rb1 treatment. However, intervention of GW9662, PPARγ antagonist, attenuated Rb1-mediated effects on glycolipid metabolism and AQP7 levels. Conclusions: These data indicated that Rb1 reduced body weight and improved glycolipid metabolism by upregulating PPARγ and AQP7 protein levels. Our study indicated a potential role for Rb1 in the prevention and treatment of obesity.